Cargando…
Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study
BACKGROUND & AIMS: In patients with chronic liver disease (CLD) with or without cirrhosis, existing studies on the outcomes with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have limited generalizability. We used the National COVID Cohort Collaborative (N3C), a harmoniz...
Autores principales: | Ge, Jin, Pletcher, Mark J., Lai, Jennifer C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286237/ https://www.ncbi.nlm.nih.gov/pubmed/34284037 http://dx.doi.org/10.1053/j.gastro.2021.07.010 |
Ejemplares similares
-
Breakthrough SARS-CoV-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study
por: Ge, Jin, et al.
Publicado: (2022) -
Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study
por: Ge, Jin, et al.
Publicado: (2021) -
Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C)
por: Martin, Blake, et al.
Publicado: (2021) -
Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection
por: Wong, Robert J., et al.
Publicado: (2023) -
487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis
por: Saunders-Hao, Patricia, et al.
Publicado: (2021)